These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 6338735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acid-induced gastric inhibitory polypeptide secretion in man.
    LeRoith D, Spitz IM, Ebert R, Liel Y, Odes S, Creutzfeldt W.
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1385-9. PubMed ID: 7002949
    [Abstract] [Full Text] [Related]

  • 6. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [Abstract] [Full Text] [Related]

  • 7. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ, Miller LJ, Service FJ, Go VL.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [Abstract] [Full Text] [Related]

  • 8. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B.
    J Clin Invest; 1996 Jan 01; 97(1):92-103. PubMed ID: 8550855
    [Abstract] [Full Text] [Related]

  • 9. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
    Lavin JH, Wittert GA, Andrews J, Yeap B, Wishart JM, Morris HA, Morley JE, Horowitz M, Read NW.
    Am J Clin Nutr; 1998 Sep 01; 68(3):591-8. PubMed ID: 9734735
    [Abstract] [Full Text] [Related]

  • 10. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R, Frerichs H, Creutzfeldt W.
    Eur J Clin Invest; 1979 Apr 01; 9(2 Pt 1):129-35. PubMed ID: 111943
    [Abstract] [Full Text] [Related]

  • 11. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R, Creutzfeldt W, Ebert R, Becker HD, Börger HW, Schafmayer A.
    Scand J Gastroenterol; 1978 Apr 01; 13(1):41-7. PubMed ID: 635445
    [Abstract] [Full Text] [Related]

  • 12. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R.
    Diabetes; 1984 Oct 01; 33(10):950-7. PubMed ID: 6383904
    [Abstract] [Full Text] [Related]

  • 13. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS, Ryan AS, Minaker KL, Elahi D.
    J Clin Endocrinol Metab; 1998 Aug 01; 83(8):2925-32. PubMed ID: 9709971
    [Abstract] [Full Text] [Related]

  • 14. Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion.
    Sirinek KR, Pace WG, Crockett SE, O'Dorisio TM, Mazzaferri EL, Cataland S.
    Am J Surg; 1978 Feb 01; 135(2):151-5. PubMed ID: 626287
    [Abstract] [Full Text] [Related]

  • 15. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
    Lauritsen KB, Lauritzen JB, Christensen KC.
    Scand J Gastroenterol; 1982 Mar 01; 17(2):241-5. PubMed ID: 6753103
    [Abstract] [Full Text] [Related]

  • 16. Effect of intraduodenal and intravenous triglyceride infusions on plasma gastric inhibitory polypeptide and insulin in fetal and neonatal pigs.
    Kühl C, Hornnes PJ, Jensen SL, Lauritsen KB.
    Diabetologia; 1982 Jul 01; 23(1):41-4. PubMed ID: 6749583
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
    Creutzfeldt W, Talaulicar M, Ebert R, Willms B.
    Diabetes; 1980 Feb 01; 29(2):140-5. PubMed ID: 6986299
    [Abstract] [Full Text] [Related]

  • 18. Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy.
    Lauritsen KB, Moesgaard F, Nielsen ML, Jensen SL.
    Scand J Gastroenterol; 1982 Jun 01; 17(4):507-11. PubMed ID: 6753107
    [Abstract] [Full Text] [Related]

  • 19. Release of gastric inhibitory polypeptide (GIP) during calcium infusion and in hyperparathyroidism.
    Toyota T, Nakanome C, Akai H, Umezu M, Goto Y.
    Regul Pept; 1982 Jun 01; 4(1):1-12. PubMed ID: 6750703
    [Abstract] [Full Text] [Related]

  • 20. The effects of xylitol on the secretion of insulin and gastric inhibitory polypeptide in man and rats.
    Salminen S, Salminen E, Marks V.
    Diabetologia; 1982 Jun 01; 22(6):480-2. PubMed ID: 7049804
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.